Marjorie Green, MD

Dr. Marjorie Green joined Seagen in October 2020 as Senior Vice President and Head of Late-Stage Oncology. Prior to joining Seagen, she held the position of Vice President, Global Head of Breast and Gynecologic Tumor Development at Genentech/Roche. Dr. Green has more than 15 years of oncology research experience, both in academics where she was a faculty member of the Breast Medical Oncology Department at the University of Texas MD Anderson Cancer Center, as well as in industry.